GlassScriptPhysician profile
Brian Israel
NPI 1740255256
$486.76
in general payments reported to CMS, 2019-2025
14 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.35 · 2020: $55.92 · 2021: $38.87 · 2022: $100 · 2023: $35.96 · 2024: $50.41 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $105.80 | 2019-2025 | |
| Hologic Sales and Service, LLC | $77.61 | 2021-2025 | Myosure Tissue Removal Device, Novasure |
| Abbvie INC. | $46.26 | 2020-2022 | |
| Coopersurgical, INC. | $45.89 | 2022-2024 | Paragard T 380a |
| Organon LLC | $33.39 | 2024-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $27.51 | 2019-2020 | |
| Minerva Surgical, INC | $26.81 | 2019 | |
| Insulet Corporation | $24.87 | 2025 | Omnipod |
| Exact Sciences Corporation | $23.10 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.65 | 2025 | Veozah |
| Biogen, INC. | $15.80 | 2025 | Zurzuvae |
| Medtronic, INC. | $14.45 | 2022 | |
| Coloplast Corp | $13.51 | 2021 | |
| Boston Scientific Corporation | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Israel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.